142 related articles for article (PubMed ID: 16226717)
1. Oxidative aldehyde deformylation catalyzed by NADPH-cytochrome P450 reductase and the flavoprotein domain of neuronal nitric oxide synthase.
Vatsis KP; Coon MJ
Biochem Biophys Res Commun; 2005 Dec; 337(4):1107-11. PubMed ID: 16226717
[TBL] [Abstract][Full Text] [Related]
2. Stopped-flow kinetic studies of electron transfer in the reductase domain of neuronal nitric oxide synthase: re-evaluation of the kinetic mechanism reveals new enzyme intermediates and variation with cytochrome P450 reductase.
Knight K; Scrutton NS
Biochem J; 2002 Oct; 367(Pt 1):19-30. PubMed ID: 12079493
[TBL] [Abstract][Full Text] [Related]
3. AFM study of membrane proteins, cytochrome P450 2B4, and NADPH-cytochrome P450 reductase and their complex formation.
Kiselyova OI; Yaminsky IV; Ivanov YD; Kanaeva IP; Kuznetsov VY; Archakov AI
Arch Biochem Biophys; 1999 Nov; 371(1):1-7. PubMed ID: 10525282
[TBL] [Abstract][Full Text] [Related]
4. Oxygen consumption and oxyradical production from microsomal reduction of aqueous extracts of cigarette tar.
Winston GW; Church DF; Cueto R; Pryor WA
Arch Biochem Biophys; 1993 Aug; 304(2):371-8. PubMed ID: 8394056
[TBL] [Abstract][Full Text] [Related]
5. Interflavin one-electron transfer in the inducible nitric oxide synthase reductase domain and NADPH-cytochrome P450 reductase.
Yamamoto K; Kimura S; Shiro Y; Iyanagi T
Arch Biochem Biophys; 2005 Aug; 440(1):65-78. PubMed ID: 16009330
[TBL] [Abstract][Full Text] [Related]
6. [Nitric oxide synthase, typical flavohemoproteins and their complicated enzymology].
Jáchymová M; Masters BS; Horký K; Zima T; Martásek P
Cas Lek Cesk; 2006; 145(7):526-31. PubMed ID: 16921779
[TBL] [Abstract][Full Text] [Related]
7. Role of Asp1393 in catalysis, flavin reduction, NADP(H) binding, FAD thermodynamics, and regulation of the nNOS flavoprotein.
Konas DW; Takaya N; Sharma M; Stuehr DJ
Biochemistry; 2006 Oct; 45(41):12596-609. PubMed ID: 17029414
[TBL] [Abstract][Full Text] [Related]
8. Structure and function of NADPH-cytochrome P450 reductase and nitric oxide synthase reductase domain.
Iyanagi T
Biochem Biophys Res Commun; 2005 Dec; 338(1):520-8. PubMed ID: 16125667
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:rat NADPH-cytochrome P450 reductase fusion protein.
Parikh A; Guengerich FP
Protein Expr Purif; 1997 Apr; 9(3):346-54. PubMed ID: 9126606
[TBL] [Abstract][Full Text] [Related]
10. Characterization of hydride transfer to flavin adenine dinucleotide in neuronal nitric oxide synthase reductase domain: geometric relationship between the nicotinamide and isoalloxazine rings.
Miller RT; Hinck AP
Arch Biochem Biophys; 2001 Nov; 395(1):129-35. PubMed ID: 11673874
[TBL] [Abstract][Full Text] [Related]
11. Reductase domain of Drosophila melanogaster nitric-oxide synthase: redox transformations, regulation, and similarity to mammalian homologues.
Ray SS; Sengupta R; Tiso M; Haque MM; Sahoo R; Konas DW; Aulak K; Regulski M; Tully T; Stuehr DJ; Ghosh S
Biochemistry; 2007 Oct; 46(42):11865-73. PubMed ID: 17900149
[TBL] [Abstract][Full Text] [Related]
12. Effects of superoxide dismutase and catalase during reduction of adrenochrome by DT-diaphorase and NADPH-cytochrome P450 reductase.
Baez S; Segura-Aguilar J
Biochem Mol Med; 1995 Oct; 56(1):37-44. PubMed ID: 8593536
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inactivation of cytochrome P450 2B4 by aldehydes: relationship to aldehyde deformylation via a peroxyhemiacetal intermediate.
Raner GM; Chiang EW; Vaz AD; Coon MJ
Biochemistry; 1997 Apr; 36(16):4895-902. PubMed ID: 9125510
[TBL] [Abstract][Full Text] [Related]
14. [Self-inactivation of cytochrome P-450 2B4 during catalytic cycle in the monooxygenase reconstituted system].
Zgoda VG; Karuzina II; Archakov AI
Vopr Med Khim; 1997; 43(4):217-25. PubMed ID: 9312936
[TBL] [Abstract][Full Text] [Related]
15. The influence of chaotropic reagents on neuronal nitric oxide synthase and its flavoprotein module. Urea and guanidine hydrochloride stimulate NADPH-cytochrome c reductase activity of both proteins.
Narayanasami R; Nishimura JS; McMillan K; Roman LJ; Shea TM; Robida AM; Horowitz PM; Masters BS
Nitric Oxide; 1997 Feb; 1(1):39-49. PubMed ID: 9701043
[TBL] [Abstract][Full Text] [Related]
16. Evidence for requirement of NADPH-cytochrome P450 oxidoreductase in the microsomal NADPH-sterol Delta7-reductase system.
Nishino H; Ishibashi T
Arch Biochem Biophys; 2000 Feb; 374(2):293-8. PubMed ID: 10666310
[TBL] [Abstract][Full Text] [Related]
17. Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4.
Vaz AD; Pernecky SJ; Raner GM; Coon MJ
Proc Natl Acad Sci U S A; 1996 May; 93(10):4644-8. PubMed ID: 8643457
[TBL] [Abstract][Full Text] [Related]
18. High reductase activity of recombinant NOS2 flavoprotein domain lacking the calmodulin binding regulatory sequence.
Rafferty S; Malech HL
Biochem Biophys Res Commun; 1996 Mar; 220(3):1002-7. PubMed ID: 8607781
[TBL] [Abstract][Full Text] [Related]
19. Engineering of proteolytically stable NADPH-cytochrome P450 reductase.
Bonina TA; Gilep AA; Estabrook RW; Usanov SA
Biochemistry (Mosc); 2005 Mar; 70(3):357-65. PubMed ID: 15823091
[TBL] [Abstract][Full Text] [Related]
20. Expression, purification, and physical properties of recombinant flavocytochrome fusion proteins containing rat cytochrome b(5) linked to NADPH-cytochrome P450 reductase by different membrane-binding segments.
Gilep AA; Guryev OL; Usanov SA; Estabrook RW
Arch Biochem Biophys; 2001 Jun; 390(2):222-34. PubMed ID: 11396925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
